Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: A combined task force of the IRLSSG, EURLSSG, and the RLS-foundation

MLA

Mark J. Buchfuhrer, et al. Guidelines for the First-Line Treatment of Restless Legs Syndrome/Willis-Ekbom Disease, Prevention and Treatment of Dopaminergic Augmentation: A Combined Task Force of the IRLSSG, EURLSSG, and the RLS-Foundation. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e6e48b818c00f05fa29e8c731b122faa&authtype=sso&custid=ns315887.

APA

Mark J. Buchfuhrer, William G. Ondo, Mauro Manconi, Juliane Winkelmann, Richard P. Allen, Michael H. Silber, Birgit Högl, Diego Garcia-Borreguero, John W. Winkelman, Yuichi Inoue, Wolfgang H. Oertel, Georgios M. Hadjigeorgiou, & Jacquelyn L. Bainbridge. (2016). Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: A combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.

Chicago

Mark J. Buchfuhrer, William G. Ondo, Mauro Manconi, Juliane Winkelmann, Richard P. Allen, Michael H. Silber, Birgit Högl, et al. 2016. “Guidelines for the First-Line Treatment of Restless Legs Syndrome/Willis-Ekbom Disease, Prevention and Treatment of Dopaminergic Augmentation: A Combined Task Force of the IRLSSG, EURLSSG, and the RLS-Foundation,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e6e48b818c00f05fa29e8c731b122faa&authtype=sso&custid=ns315887.